| pubmed-article:8343238 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8343238 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
| pubmed-article:8343238 | lifeskim:mentions | umls-concept:C0022663 | lld:lifeskim |
| pubmed-article:8343238 | lifeskim:mentions | umls-concept:C0023870 | lld:lifeskim |
| pubmed-article:8343238 | lifeskim:mentions | umls-concept:C0597484 | lld:lifeskim |
| pubmed-article:8343238 | pubmed:issue | 6 Pt 1 | lld:pubmed |
| pubmed-article:8343238 | pubmed:dateCreated | 1993-9-3 | lld:pubmed |
| pubmed-article:8343238 | pubmed:abstractText | Erythrocyte Na+/Li+ countertransport activity was investigated in 11 controls and 22 recent onset type I (insulin-dependent) diabetic patients with normal and high glomerular filtration rates. No differences in Vmax were observed in hyperfiltering compared to normofiltering patients or controls. The Na+/Li+ activity was correlated with blood glucose levels in insulin-dependent diabetics showing good glycemic control. Total cholesterol and triglyceride concentrations were similar among the three groups. In conclusion, enhanced Na+/Li+ countertransport activity is not associated, in our case, with diabetic condition per se and with early glomerular hyperfiltration and cannot be used as a marker of renal involvement in recent onset insulin-dependent diabetics. | lld:pubmed |
| pubmed-article:8343238 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8343238 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8343238 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8343238 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8343238 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8343238 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8343238 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8343238 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8343238 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8343238 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8343238 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:8343238 | pubmed:issn | 0895-7061 | lld:pubmed |
| pubmed-article:8343238 | pubmed:author | pubmed-author:RothII | lld:pubmed |
| pubmed-article:8343238 | pubmed:author | pubmed-author:GuicheneyPP | lld:pubmed |
| pubmed-article:8343238 | pubmed:author | pubmed-author:TimsitJJ | lld:pubmed |
| pubmed-article:8343238 | pubmed:author | pubmed-author:BoitardCC | lld:pubmed |
| pubmed-article:8343238 | pubmed:author | pubmed-author:HannedoucheTT | lld:pubmed |
| pubmed-article:8343238 | pubmed:author | pubmed-author:IkeniAA | lld:pubmed |
| pubmed-article:8343238 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8343238 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:8343238 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8343238 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8343238 | pubmed:pagination | 534-7 | lld:pubmed |
| pubmed-article:8343238 | pubmed:dateRevised | 2009-2-24 | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:meshHeading | pubmed-meshheading:8343238-... | lld:pubmed |
| pubmed-article:8343238 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8343238 | pubmed:articleTitle | Erythrocyte Na+/Li+ countertransport and glomerular hyperfiltration in insulin-dependent diabetics. | lld:pubmed |
| pubmed-article:8343238 | pubmed:affiliation | Département de Néphrologie, Hôpital Necker, Paris, France. | lld:pubmed |
| pubmed-article:8343238 | pubmed:publicationType | Journal Article | lld:pubmed |
